Ultragenyx Pharmaceutical | RARE - El Costo De Ventas

Precio De Mercado
24.89
Cambio Diario
-0.12 -0.48%
Mensual
7.52%
Anual
-25.52%
Q2 Expectativa
24.25




El Costo De Ventas Cambio Fecha
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Insmed USD 46.16M 15.25M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Kyowa Hakko Kirin JPY 37.87B 9.67B 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Moderna USD 955M 503M 2026-03
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03
Xoma 116K 112.7K 2024-06